FLUDARABIN Accord conc perf 50 mg/2ml flac
7680667500018
CH-66750
L01BB05
07.16.1.
Reimbursement limitations:
FLUDARA
Traitement de la leucémie lymphoïde chronique (LLC) à cellules B. Le traitement de première intention …
1 / 3
google
Details
- Product number
- 6675001
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- fludarabini phosphas 50 mg, mannitolum, dinatrii phosphas dihydricus corresp. natrium 16.15 mg, aqua ad iniectabile q.s. ad solutionem pro 2 ml.
Articles (1)
Fludarabin Accord 25 mg/ml, Konzentrat zur Herstellung einer Injektions- /Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
16.15 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 163.70
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/07/2019
Authorization holder
Accord Healthcare AG
4103 Bottmingen
Authorization information
- Swissmedic authorization number
- 66750
- Drug name
- Fludarabin Accord, Konzentrat zur Herstellung einer Injektions-/Infusionslösung
- Galenic form
- KOIN
- ATC Code
- L01BB05
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 15/08/2018
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- FLUDARABIN Accord conc perf 50 mg/2ml flac
- Description (DE)
- FLUDARABIN Accord Inf Konz 50 mg/2ml Durchstf
- Market launch
- 15/08/2018
- Narcotic (BTM)
- No